Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR3 | O15455 | 1/20 | 1.00 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.61 |
| ▸ | PRNP | P04156 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | BCKDK | O14874 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11951244 | 1.00 | TLR3 (1.00) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11301956 | 1.00 | TLR3 (1.00) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11298597 | 0.92 | TLR3 (0.84) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11950492 | 0.92 | TLR3 (0.84) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11950491 | 0.92 | TLR3 (0.84) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11500750 | 0.91 | TLR3 (0.84) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11951271 | 0.91 | TLR3 (0.84) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11300435 | 0.91 | TLR3 (0.84) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11498991 | 0.89 | TLR3 (0.80) | TLR3SENP1PRNPNPSR1RXFP1 | |
| SCHEMBL11950554 | 0.89 | TLR3 (0.80) | TLR3SENP1PRNPNPSR1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025030019-A1 | TARGETING TLR3 FOR TREATMENT OF HEMATOPOIETIC STEM CELL PROLIFERATION-ASSOCIATED DISEASES OR DISORDERS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-02-06 | — | — | WO | claimed |
| US-20250011869-A1 | TLR3 INHIBITORS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH CARDIOVASCULAR CALCIFICATION | HOLFELD, Johannes (AT) | 2025-01-09 | — | — | US | claimed |
| EP-4419098-A2 | TLR3 INHIBITORS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH CARDIOVASCULAR CALCIFICATION | Holfeld, Johannes (AT) | 2024-08-28 | — | — | EP | claimed |
| WO-2023066949-A2 | MATERIALS AND METHODS FOR THE DIAGNOSIS, PROGNOSIS, PROPHYLAXIS AND TREATMENT OF DISEASES ASSOCIATED WITH CARDIOVASCULAR CALCIFICATION | HOLFELD JOHANNES (AT) | 2023-04-27 | — | — | WO | claimed |
| WO-2025030019-A1 | TARGETING TLR3 FOR TREATMENT OF HEMATOPOIETIC STEM CELL PROLIFERATION-ASSOCIATED DISEASES OR DISORDERS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-02-06 | — | — | WO | disclosed |
| US-20250011869-A1 | TLR3 INHIBITORS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH CARDIOVASCULAR CALCIFICATION | HOLFELD, Johannes (AT) | 2025-01-09 | — | — | US | disclosed |
| EP-4419098-A2 | TLR3 INHIBITORS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH CARDIOVASCULAR CALCIFICATION | Holfeld, Johannes (AT) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023066949-A2 | MATERIALS AND METHODS FOR THE DIAGNOSIS, PROGNOSIS, PROPHYLAXIS AND TREATMENT OF DISEASES ASSOCIATED WITH CARDIOVASCULAR CALCIFICATION | HOLFELD JOHANNES (AT) | 2023-04-27 | — | — | WO | disclosed |
| CN-105251006-B | Purposes of the TLR3 inhibitor in the drug for preparing treatment cocaine habituation | 四川大学 | 2018-08-03 | — | — | CN | disclosed |
| US-9409880-B2 | Modulators of TLR3/dsRNA complex and uses thereof | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2016-08-09 | — | — | US | disclosed |
| US-9409880-B2 | Modulators of TLR3/dsRNA complex and uses thereof | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2016-08-09 | — | — | US | disclosed |
| US-9409880-B2 | Modulators of TLR3/dsRNA complex and uses thereof | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2016-08-09 | — | — | US | disclosed |
| WO-2012099785-A2 | MODULATORS OF TLR3/DSRNA COMPLEX AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2012-07-26 | — | — | WO | disclosed |